Post by AIRNA

It was great to connect with the Alpha-1 community at the A1F National Conference last week, where AIRNA CMO Jacob Elkins presented on our lead clinical candidate AIR-001 and the ongoing RepAIR1 Phase 1 clinical trial. As the largest annual gathering of the Alpha-1 community, it was an honor to sponsor the conference and connect with peer researchers, physicians, and patients who share our commitment to transforming the treatment landscape for those living with AATD. Thank you to the Alpha-1 Foundation for organizing this event — hope to see you again next year! #A1FNC26 #AATD #RNAEditing